BioCatalyst

CLRB — Cellectar Biosciences, Inc. catalysts

1 verified catalyst event(s) for Cellectar Biosciences, Inc. (ticker CLRB). Each is linked to its official source. Verified as of 2026-06-22.

Next verified catalyst

2026-06-22 — Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansio · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-06-22
today
ESTIMATED
 READOUT
Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) Wit
Phase 2 · Waldenstrom Macroglobulinemia, Multiple Myeloma
 CLRB Cellectar Biosciences, Inc. Iopofosine I 131 single dose, Iopofosine ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.